Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · IEX Real-Time Price · USD
26.27
-2.60 (-9.01%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $771.01 million as of July 2, 2024. Its market cap has increased by 1,851.93% in one year.
Market Cap
771.01M
Enterprise Value
394.47M
1-Year Change
1,851.93%
Ranking
Category
Stock Price
$26.27
Market Cap Chart
Since June 21, 2018, Dianthus Therapeutics's market cap has increased from $499.10M to $771.01M, an increase of 54.48%. That is a compound annual growth rate of 7.47%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 847.30M | 449.84% |
Dec 29, 2023 | 154.10M | 544.77% |
Dec 30, 2022 | 23.90M | -90.82% |
Dec 31, 2021 | 260.40M | -31.24% |
Dec 31, 2020 | 378.70M | -35.93% |
Dec 31, 2019 | 591.10M | 212.75% |
Dec 31, 2018 | 189.00M | -62.13% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Cogent Biosciences | 806.02M |
Atrion | 796.25M |
89bio | 788.06M |
Healthcare Services Group | 779.18M |
CureVac | 762.64M |
CARGO Therapeutics | 753.05M |
Alumis | 749.72M |
Ginkgo Bioworks Holdings | 739.23M |